These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8208135)

  • 1. Industrial Genotoxicology Group: novel in vivo genotoxicity assays, Royal Society of Medicine, London, UK, December 1992.
    Jones E
    Mutagenesis; 1994 Jan; 9(1):79-80. PubMed ID: 8208135
    [No Abstract]   [Full Text] [Related]  

  • 2. Industrial Genotoxicology Group (IGG): cytotoxicity in vitro, Royal Society of Medicine, London, UK, 6 December 1999.
    Clare G; Clements J
    Mutagenesis; 2001 Mar; 16(2):179-82. PubMed ID: 11230562
    [No Abstract]   [Full Text] [Related]  

  • 3. Industrial Genotoxicology Group: transgenic animals in genotoxicity assays and the comet assay, Royal Society of Medicine, London, UK, May 1995.
    Jenkinson P
    Mutagenesis; 1996 Mar; 11(2):217-8. PubMed ID: 8671742
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of the potential in vivo genotoxicity of fluoranthene.
    Stocker KJ; Howard WR; Statham J; Proudlock RJ
    Mutagenesis; 1996 Sep; 11(5):493-6. PubMed ID: 8921511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Industrial Genotoxicology Group: automation of genotoxicity assays and structure-activity relationships, Unicorn House, the Wellcome Foundation, London, UK, December 1993.
    Mackay JM
    Mutagenesis; 1994 Nov; 9(6):571-2. PubMed ID: 7854150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genotoxicity evaluation of nanoparticles].
    Durnev AD
    Gig Sanit; 2014; (2):76-83. PubMed ID: 25051747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
    Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in genotoxicology: Acceptance of innovative scientific methods in a regulatory context and from an industrial perspective.
    Steiblen G; Benthem JV; Johnson G
    Mutat Res Genet Toxicol Environ Mutagen; 2020 May; 853():503171. PubMed ID: 32522346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comet assay (single-cell gel test). A sensitive genotoxicity test for the detection of DNA damage and repair.
    Speit G; Hartmann A
    Methods Mol Biol; 1999; 113():203-12. PubMed ID: 10443422
    [No Abstract]   [Full Text] [Related]  

  • 10. Gonadal genotoxicity assays as practical surrogates for germ-cell mutagenicity assays.
    Ashby J
    Environ Mutagen; 1985; 7(3):263-6. PubMed ID: 3840087
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-ranging and dose-setting for in vivo genetic toxicology studies.
    Mackay JM; Elliott BM
    Mutat Res; 1992 Feb; 271(1):97-9. PubMed ID: 1371834
    [No Abstract]   [Full Text] [Related]  

  • 12. Industrial Genotoxicology Group collaborative trial to investigate cell cycle parameters in human lymphocyte cytogenetics studies.
    Henderson L; Jones E; Brooks T; Chételat A; Ciliutti P; Freemantle M; Howard CA; Mackay J; Phillips B; Riley S; Roberts C; Wotton AK; van de Waart EJ
    Mutagenesis; 1997 May; 12(3):163-7. PubMed ID: 9175642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives in the use of Drosophila melanogaster in genotoxicity testing.
    Zordan M; Costa R; Levis AG
    Prog Clin Biol Res; 1991; 372():423-31. PubMed ID: 1956936
    [No Abstract]   [Full Text] [Related]  

  • 14. A proposal for a novel rationale for critical effect size in dose-response analysis based on a multi-endpoint in vivo study with methyl methanesulfonate.
    Zeller A; Tang L; Dertinger SD; Funk J; Duran-Pacheco G; Guérard M
    Mutagenesis; 2016 May; 31(3):239-53. PubMed ID: 26590612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the follow-up of positive results in the in vitro genotoxicity assays--an international collaborative initiative.
    Gollapudi BB; Thybaud V; Kim JH; Holsapple M
    Environ Mol Mutagen; 2011 Apr; 52(3):174-6. PubMed ID: 20740633
    [No Abstract]   [Full Text] [Related]  

  • 16. Where will genetic toxicology testing be in 30 years' time? Summary report of the 25th Industrial Genotoxicity Group Meeting, Royal Society of Medicine, London, November 9, 2011.
    Ellis P; Fowler P; Booth E; Kidd D; Howe J; Doherty A; Scott A
    Mutagenesis; 2014 Jan; 29(1):73-7. PubMed ID: 24334751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of short-term tests to safety testing of industrial chemicals.
    Schreiner CA
    Ann N Y Acad Sci; 1983; 407():367-73. PubMed ID: 6349486
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro genotoxicity testing-Can the performance be enhanced?
    Corvi R; Madia F
    Food Chem Toxicol; 2017 Aug; 106(Pt B):600-608. PubMed ID: 27554597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of modified bacterial mutagenicity assays for the genotoxicity testing of mineral oils.
    Brooks TM; Priston RA; Wright AS; Watson WP
    Mutagenesis; 1995 Sep; 10(5):409-15. PubMed ID: 8544754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity of engineered nanomaterials.
    Donner M; Tran L; Muller J; Vrijhof H
    Nanotoxicology; 2010 Dec; 4():345-6. PubMed ID: 20925444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.